0% Annual Report Loaded

global EXPANSION

Home Corporate Overview

We are strategically consolidating and maintaining sustainable growth in our core markets, while consistently foraying into new geographies to augment future growth.

In the last few years, we have seen a robust growth in our core markets of USA, Canada, Europe, Australia and India. In accordance with our future global expansion plans, we are augmenting our presence as a leading generic injectable manufacturer in key markets.

At the same time, we are also strategically focusing on expanding our presence in ‘Rest of the World’ (ROW) markets to further fortify our position globally. We have seen promising response from the markets we recently entered, including Singapore, Israel, Saudi Arabia and CIS countries. We intend to enter the China market, leveraging the credentials of our parent company, Fosun Pharma.

Exports to

60+

Countries

Share of revenue from
international markets in
FY 2020-21